Optima Medical Innovations Corp.
TOKIF · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $5 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $2 | $1 |
| Enterprise Value | $4 | $3 | $7 | $3 |
| Revenue | $1 | $1 | $1 | -$1 |
| % Growth | 20.2% | -21.3% | 189.5% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 2.1% | -3.2% | -19.1% | 36.8% |
| EBITDA | -$0 | $0 | $0 | $1 |
| % Margin | -3.3% | 22.3% | 18.5% | -74.7% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -22.9% | 3.2% | -6.5% | 4.3% |
| EPS Diluted | -0.005 | 0 | -0.002 | -1.13 |
| % Growth | -5,200% | 106.7% | 99.9% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |